Application of a kind of brefeldin a in the preparation of inflammatory factor activity inhibitor medicine
A Brefeldin bacteria and activity inhibitor technology, applied in the application field of Brefeldin A in the preparation of inflammatory factor activity inhibitor drugs, to achieve the effect of improving pathological changes
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] 1 Materials and methods
[0031] 1.1 Experimental animals C57 / BL6 mice, male, body weight 19-21g, clean grade, provided by the Experimental Center of Zhejiang University School of Medicine, certificate number: (SCXK2013-0016). All operations and experimental procedures complied with the "Regulations on the Management of Experimental Animals". Experimental environment: constant temperature (22±2)°C, humidity 60%-70%, free drinking and eating.
[0032] 1.2 Reagents and instruments LPS (Escherichia coli LPS O55:B5, L2880, sigma); Brefeldin A (BFA, sigma); dexamethasone (DXM, 5mg / ml, Zhejiang Xianju Pharmaceutical Co., Ltd.), myeloperoxidase (myeloperoxidase, MPO) kit (Nanjing Jiancheng Biotechnology Co., Ltd., A044); TNF-α (tumornecrosis factor-α), IL-1β (interleukin-1β) and IL-6 (interleukin-6) ELISA kits were purchased from R&D Systems (R&D Systems, Mineapolis, MN, USA, DY410, DY401, DY406); Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA, 500-0120); Cyclic Adeno...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com